… the distribution of variants of genes involved in gemcitabine pharmacology in ethnic Asian
populations and their association with non-small cell lung cancer (NSCLC) patient outcome. …

… treatment in NSCLC patients without progression after first-line chemotherapy. We report
a retrospective subanalysis of Asian patients enrolled in SATURN. Patients with advanced …

… the results of patients with advanced non-small-cell lung cancer treated with gefitinib to
derive clinical factors predictive of response and a favourable survival outcome. Patients were …

… -line treatment in patients with advanced non–small-cell lung cancer (NSCLC). We report
the results of a preplanned analysis of Asian patients enrolled in AVAiL. Methods: Patients with …

… , individuals of Asian ethnicity and adenocarcinoma patients (21). … , respectively, with a higher
frequency in Asia (35.7%) (22). … in Asian lung cancer patients than non-Asian patients. The …

… with those of a clinic-based study in Boston, where Asian immigrants with lung cancer had
significantly poorer 2-year survival than non-Asians (13). However, none of these studies …

… However, the predictive value of evaluating p27 expression in East Asian patients was more
prominent. Additionally, in East Asian populations, a significant association was found for …

… therapy selection and development for Chinese patients. Here we report an … Chinese patients
with non-small cell lung cancer. Tumor-infiltrating lymphocyte estimated using immune cell …

… in lung cancer. In this study, we ran NGS on 122 Chinese SCLC patients tumor sample and
… We identified some unique genetic variant features in Chinese SCLC patients and further …

… for the Asian … the Asian subpopulation versus chemotherapy alone and had a manageable
safety profile, supporting its use as first-line treatment for advanced NSCLC in Asian patients. …